An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
| Status: | Terminated |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/13/2017 |
| Start Date: | October 2012 |
| End Date: | June 1, 2015 |
A Prospective Evaluation of the Effect of Training on Eye Drop Administration in Glaucoma Subjects Who Have Difficulties Properly Instilling Eye Drops
This is a prospective, observational, single-center study. Patients with at least 3 months
of experience using topical medications for glaucoma and who state that they administer
their own eye drops will be recruited. Subjects will be videotaped instilling a sterile
artificial eye drop, will be identified at the time of a regularly scheduled exam. If the
patient can get a drop onto the eye and also not touch their lids or ocular surface with the
eye drop bottle, the subject will be thanked but not enrolled. All other patients who agree
to participate will be enrolled. Upon completion of videotaped instillation of an eye drop,
each enrolled patient will be shown a video demonstrating an instillation technique and will
be given an instructional handout highlighting a proper drop instillation technique. If
necessary, an instillation technique will be demonstrated to them by an investigator or
trained personnel.
A patient will be identified as properly instilling a drop if they satisfy the following
criteia:
They are able to instill one (and only one) drop to the ocular surface or lower fornix
without allowing the bottle touch the adnexa, eyelid, eye lashes or eye.
All patients routinely return between 3 and 6 months. At this regularly scheduled visit,the
investigator or trained personnel would direct the patient to instill an eye drop into the
study eye.Additionally, the short glaucoma self-efficacy questionnaire will be
re-administered.
All of the video-recordings of participants' eye drop instillation techniques will be
reviewed and assessed using a standard checklist. Their ability to administer an eye drop
after training will be compared to baseline.
of experience using topical medications for glaucoma and who state that they administer
their own eye drops will be recruited. Subjects will be videotaped instilling a sterile
artificial eye drop, will be identified at the time of a regularly scheduled exam. If the
patient can get a drop onto the eye and also not touch their lids or ocular surface with the
eye drop bottle, the subject will be thanked but not enrolled. All other patients who agree
to participate will be enrolled. Upon completion of videotaped instillation of an eye drop,
each enrolled patient will be shown a video demonstrating an instillation technique and will
be given an instructional handout highlighting a proper drop instillation technique. If
necessary, an instillation technique will be demonstrated to them by an investigator or
trained personnel.
A patient will be identified as properly instilling a drop if they satisfy the following
criteia:
They are able to instill one (and only one) drop to the ocular surface or lower fornix
without allowing the bottle touch the adnexa, eyelid, eye lashes or eye.
All patients routinely return between 3 and 6 months. At this regularly scheduled visit,the
investigator or trained personnel would direct the patient to instill an eye drop into the
study eye.Additionally, the short glaucoma self-efficacy questionnaire will be
re-administered.
All of the video-recordings of participants' eye drop instillation techniques will be
reviewed and assessed using a standard checklist. Their ability to administer an eye drop
after training will be compared to baseline.
Inclusion Criteria:
- Patients aged 18 years or older
- Patients currently using topical ocular antihypertensive medications at the time of
enrollment in at least one eye, and who have been using these drops consistently for
a period of at least three months prior to enrollment.
- Patients with primary open angle glaucoma, pigmentary glaucoma, exfoliation glaucoma,
ocular hypertension, normal-tension glaucoma, neovascular glaucoma, uveitic glaucoma
and chronic narrow angle glaucoma.
- Patients CAN be enrolled even if they have co-existing morbidities such as
Parkinson's Disease or arthritis
Exclusion Criteria:
- Patients who do not instill their own eye drops
- Patients who are not expected to still be using topical antihypertensive medications
at the time of study follow-up
- Patients with no light perception vision
- Patients with a history of adverse reaction to artificial tears or any component of
artificial tears
- Patients who have a typical follow-up period of greater than 6 months
- Patients who have not completed a Humphrey Visual Field C24-2 or C10-2 within 7
months of enrollment or study exit.
We found this trial at
1
site
Click here to add this to my saved trials
